MGMT methylation: Is it time to embrace the shades of grey?

Journal Article Accepted manuscript MGMT methylation: Is it time to be embrace the shades of grey? Get access H K Gan, MBBS, PhD H K Gan, MBBS, PhD Cancer Therapies and Biology Group, and Centre for Research Excellence in Brain Cancer, Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, AustraliaLa Trobe University School of Cancer Medicine, Heidelberg, Victoria, AustraliaDepartment of Medicine, University of Melbourne, Heidelberg, Victoria, AustraliaAustralian Brain Cancer Research Alliance, Melbourne, Australia Corresponding author: HK Gan, MBBS, PhD, Olivia Newton-John Cancer Research Institute, Austin Health, 145 Studley Road, Heidelberg, Melbourne, Victoria 3084, Australia; Tel: + 61 3 9495 9925; Fax: +61 3 9457 6698; Email: hui.gan@onjcri.org.au Search for other works by this author on: Oxford Academic Google Scholar Neuro-Oncology Practice, npad003, https://doi.org/10.1093/nop/npad003 Published: 03 February 2023 Article history Received: 07 January 2023 Published: 03 February 2023